Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,244,305 papers from all fields of science
Search
Sign In
Create Free Account
MAP2K2 wt Allele
Known as:
MEK2
, Mitogen-Activated Protein Kinase Kinase 2 wt Allele
, MAPKK2
Expand
Human MAP2K2 wild-type allele is located in the vicinity of 19p13.3 and is approximately 34 kb in length. This allele, which encodes dual specificity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
35 relations
19p13.3
Angiotensin II Signaling Pathway
B Cell Receptor Signaling Pathway
Calpain-2 Cell Motility Pathway
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
[Effect of reinforcing qi for resolving masses method on expressions of MEK2 and p-ERK protein in estrogen induced uterine leiomyoma model guinea pigs' uterine tissue].
Na Wang
,
Zhuo-min Song
,
Shi-Shui Ruan
Zhongguo Zhong xi yi jie he za zhi Zhongguo…
2013
Corpus ID: 1993866
OBJECTIVE To explore the effect of reinforcing qi for resolving masses method (RQRMM) on expressions of extracellular signal…
Expand
2013
2013
Clinical and Molecular Characteristics of Cardio-facio-cutaneous Syndrome in Hong Kong Chinese
H. Luk
,
Y. Aoki
,
S. Lam
2013
Corpus ID: 73877153
Cardio-facio-cutaneous (CFC) syndrome is a rare disorder of RASopathy that is caused by dysregulation of the RAS/MAPK signaling…
Expand
2012
2012
Bryostatin analog: improving on Nature's design
D. Boger
OncoTarget
2012
Corpus ID: 5262164
// Commentary on: Dechristopher B et al. “Picolog,” a synthetically-available bryostatin analog, inhibits growth of MYC-induced…
Expand
2011
2011
Cardiofaciocutaneous syndrome in a mother and two sons with a MEK2 mutation.
Helen Linden
,
S. Price
Clinical Dysmorphology
2011
Corpus ID: 9588743
Introduction Cardiofaciocutaneous (CFC) syndrome is a heterogeneous disorder characterized by craniofacial and ectodermal…
Expand
2011
2011
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436).
K. Nathanson
,
A. Martín
,
+11 authors
R. Kefford
Journal of Clinical Oncology
2011
Corpus ID: 43039818
8501 Background: GSK436 is a highly potent, selective ATP-competitive BRAF inhibitor. BRF112680, a first in human study, assessed…
Expand
2001
2001
PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation.
N. Cartel
,
N. Cartel
,
Jason Liu
,
Jinxia Wang
,
M. Post
American Journal of Physiology - Lung cellular…
2001
Corpus ID: 25931511
Herein, we investigated the activity of mitogen-activated protein kinase (MAPK), a key component of downstream signaling events…
Expand
2001
2001
A Potent Non-Peptide Inhibitor of Anthrax Lethal Factor
V. Yalamoori
,
M. G. Luna
,
+7 authors
K. Ramnarayan
2001
Corpus ID: 79408424
Bacillus anthracis, the cause of anthrax, poses a considerable danger because of its potential use as a weapon by military…
Expand
1997
1997
Differential Expression of MEKI and MEK2 during Mouse Development1
B. Brott
,
R. Erikson
1997
Corpus ID: 53517038
Map/Erk kinase I (MEKI) and MEK2 activate the Erk/ MAP kinases and have been implicated in cell growth and differentiation. To…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE